Monoclonal antibody manufacturing in transgenic plants - myths and realities
Monoclonal antibody manufacturing in transgenic plants - myths and realities
- Current Opinion in Biotechnology, 13(6), p.630-635, 2002 .
The number and types of antibodies expressed in plants has increased steadily since the first reports of this accomplishment in the 1980s, illustrating the versatility of plants as a production system for antibodies. Many recent reviews have detailed the antibody forms that have been derived from plant expression systems. This contribution focuses on the remaining challenges to develop plant-derived therapeutic antibodies into products, and some of the progress that is being made in addressing these challenges. Plants are proving to be a versatile system for the production of antibodies, but some challenges remain
MAB
TRANSGENIC PLANTS
MOLECULAR FARMING
GLYCOSYLATION
CONTAINMENT
MANUFACTURING CAPACITY
AVIDIN
The number and types of antibodies expressed in plants has increased steadily since the first reports of this accomplishment in the 1980s, illustrating the versatility of plants as a production system for antibodies. Many recent reviews have detailed the antibody forms that have been derived from plant expression systems. This contribution focuses on the remaining challenges to develop plant-derived therapeutic antibodies into products, and some of the progress that is being made in addressing these challenges. Plants are proving to be a versatile system for the production of antibodies, but some challenges remain
MAB
TRANSGENIC PLANTS
MOLECULAR FARMING
GLYCOSYLATION
CONTAINMENT
MANUFACTURING CAPACITY
AVIDIN